title: Glucose Tranporter-4 expression in monocytes: a systematic review.
abstract: OBJECTIVE
  The purpose of this review was to systematically assess the extent of current knowledge of Glucose Tranporter-4 (GLUT-4) expression in monocytes in humans to address its potential use as a non-invasive and reliable model to investigate the relationships between insulin signalling, GLUT-4 expression and insulin action in vivo.
  
  
  METHODS
  Electronic database searches were performed with the keywords 'monocyte', 'leukocyte' and 'white blood cells', and the terms 'GLUT', 'glucose transporter' and 'SLC2A4' (solute carrier family 2 member 4). Studies were examined for robustness of design and outcomes by consensus of three reviewers.
  
  
  RESULTS
  Six cross-sectional or observational studies met the criteria for review. Insulin-stimulated GLUT-4 expression in monocytes from subjects likely to have impaired insulin sensitivity appeared blunted relative to healthy subjects.
  
  
  CONCLUSIONS
  The available results provide evidence that monocyte GLUT-4 translocation does occur in response to acute insulin exposure, and may be sensitive to the relative state of insulin resistance of the individual. However, due to the limited quantity and robustness of published data, the ultimate utility of monocyte GLUT-4 expression as an index of whole body insulin responsiveness and the clinical relevance of this methodology is unresolved at this time.
authors.affiliation: Exercise, Health and Performance Faculty Research Group, Faculty of Health Sciences, University of Sydney, East Street, Lidcombe, Sydney, NSW 2141, Australia. ymav5521@mail.usyd.edu.au
authors.forename: Yorgi
authors.initials: Y
authors.lastname: Mavros
authors.forename: David
authors.initials: D
authors.lastname: Simar
authors.forename: Maria A Fiatarone
authors.initials: MA
authors.lastname: Singh
mesh_terms: D003430:Cross-Sectional Studies; D003920:Diabetes Mellitus / Q000097:blood / Q000503:physiopathology*; D051275:Glucose Transporter Type 4 / Q000097:blood* / Q000187:drug effects; D006801:Humans; D007328:Insulin / Q000494:pharmacology*; D007333:Insulin Resistance; D009000:Monocytes / Q000502:physiology*; D018579:Patient Selection; D012016:Reference Values
chemical_list: D051275:Glucose Transporter Type 4; D007328:Insulin